Lithium augmentation in venlafaxine-refractory depression.
Zullino
D
D
Preisig
M
M
Baumann
P
P
D018692:Antimanic Agents / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D018021:Lithium Chloride / Q000627:therapeutic use*; D008875:Middle Aged; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D018692:Antimanic Agents; D003511:Cyclohexanols; D018021:Lithium Chloride; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride